Crossmark

Critical commentary on camrelizumab-based triple therapy for unresectable hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1016/j.aohep.2025.101940

Published Print: 2025-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Hassan, Ibrahim Nagmeldin https://orcid.org/0009-0003-3331-8138
License Information

Text and Data Mining valid from 2025-07-01

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-06-25
More Information

This article is maintained by: Elsevier

Article Title: Critical commentary on camrelizumab-based triple therapy for unresectable hepatocellular carcinoma

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2025.101940

Content Type: simple-article

Copyright: © 2025 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.